RBC Europe’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$258K Hold
2,780
0.01% 185
2022
Q1
$281K Hold
2,780
0.01% 193
2021
Q4
$287K Buy
2,780
+599
+27% +$55.4K 0.01% 197
2021
Q3
$185K Sell
2,181
-186
-8% -$15.6K 0.01% 312
2021
Q2
$198K Sell
2,367
-41
-2% -$3.36K 0.01% 317
2021
Q1
$181K Hold
2,408
0.01% 303
2020
Q4
$164K Hold
2,408
0.01% 315
2020
Q3
$141K Sell
2,408
-272
-10% -$16.9K 0.01% 305
2020
Q2
$174K Buy
2,680
+100
+4% +$6.3K 0.01% 261
2020
Q1
$153K Buy
2,580
+105
+4% +$7.01K 0.02% 246
2019
Q4
$184K Sell
2,475
-87
-3% -$6.11K 0.02% 259
2019
Q3
$162K Sell
2,562
-220
-8% -$13K 0.02% 266
2019
Q2
$152K Buy
2,782
+167
+6% +$8.99K 0.02% 277
2019
Q1
$141K Hold
2,615
0.02% 283
2018
Q4
$171K Buy
2,615
+41
+2% +$3.06K 0.02% 240
2018
Q3
$203K Sell
2,574
-372
-13% -$26.6K 0.02% 246
2018
Q2
$190K Buy
2,946
+5
+0.2% +$330 0.02% 252
2018
Q1
$183K Hold
2,941
0.02% 259
2017
Q4
$213K Sell
2,941
-915
-24% -$66.5K 0.03% 239
2017
Q3
$314K Buy
+3,856
New +$305K 0.04% 196

Other funds holding CVS

RBC Europe's CVS Position: Q2 2022 in Review

RBC Europe held its CVS Health (CVS) position steady in Q2 2022 at 2,780 shares worth $258K. The position accounts for 0.01% of the portfolio, ranked #185.

RBC Europe first reported a position in CVS in Q3 2017 and has held it in 20 quarters since. The position peaked at $314K in Q3 2017. 2,308 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

  • RBC Europe held 2,780 shares of CVS Health worth $258K as of Q2 2022.
  • RBC Europe left its CVS Health share count unchanged in Q2 2022.
  • CVS Health made up 0.01% of RBC Europe's portfolio in Q2 2022, its #185 holding.
  • RBC Europe first reported a position in CVS Health in Q3 2017 and has held it in 20 quarters since.
  • RBC Europe's CVS Health position peaked at $314K in Q3 2017.
  • 2,308 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.